Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine
Disease Category: Clostridium Difficile-Associated Diarrhea
Location: United States, NY
Let’s Try to Break the Cycle
If a patient has C. diff now, they have up to a 60% chance of having C. diff again.*
The MODIFY Study in testing the safety, effectiveness and tolerability of an investigational drug to see if it can help prevent C. diff reoccurrences.
Participants will receive study-related exams and study drug at no charge. There are risks associated with participation in this clinical research study. They study doctor will explain the study requirements, possible benefits, and potential risks to you before you decide to participate.
Patient Inclusion Criteria:
Eligible participants must:
CW ID: 180813
Date Last Changed:
July 19, 2013
Lorraine Breuer, Vice President for ResearchParker Jewish Institute271-11 76th AvenueNew Hyde Park, NY 11040Phone: 718-289-2102Fax: 718-289-2248
Parker Jewish Institute
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2016 CenterWatch.